Medical Developments International

Medical Developments International EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Medical Developments International (MVP.AX) as of Oct 18, 2026 is 1.54 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 4.63 % — a change of -66.70% (lower).

EBIT/Assets

1.54 %

YoY

-66.70%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Medical Developments International is 2026 1.54 % . Operating Income to Assets Ratio (EBIT/Assets) of Medical Developments International was 2025 4.63 % . It decreases by -66.70% lower compared to the previous year.

The Medical Developments International EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
3.74 AUD
Jan 1, 2020
0.46 AUD
Jan 1, 2021
-5.23 AUD
Jan 1, 2022
-15.64 AUD
Jan 1, 2023
-18.67 AUD
Jan 1, 2024
-28.51 AUD
Jan 1, 2025
4.63 AUD
Jan 1, 2026
1.54 AUD
The Medical Developments International EBIT/Assets history
YEAREBIT/AssetsYoY
1.54 %-66.70%
4.63 %-116.23%
-28.51 %+52.70%
-18.67 %+19.40%
-15.64 %+199.01%
-5.23 %-1,240.36%
0.46 %-87.74%
3.74 %+320.39%
0.89 %-89.38%
8.38 %-2.78%
8.62 %-32.39%
12.75 %+68.27%
7.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medical Developments International Stock analysis

What does Medical Developments International do? Medical Developments International Ltd is an Australian company specializing in the development and production of medical devices and products. The company was founded in 1971 by renowned researcher and entrepreneur Mark Sullivan and has since received numerous awards and accolades. The company's business model is based on the manufacture of emergency medical devices and products of the highest quality and effectiveness. It has three main business segments: Pharmaceuticals, Medical devices, and Animal health. Medical Developments International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medical Developments International stock

Operating Income to Assets Ratio (EBIT/Assets) of Medical Developments International is 1.54 % in 2026.

Operating Income to Assets Ratio (EBIT/Assets) of Medical Developments International changed from 4.63 % to 1.54 %, representing a -66.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Medical Developments International since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Medical Developments International with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Medical Developments International

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Medical Developments International